Evidence map›Paper›PMID 35273659›Full record

ArticleThe EPMA journal2022

Predictive factors, preventive implications, and personalized surgical strategies for bone metastasis from lung cancer: population-based approach with a comprehensive cancer center-based study.

Xianglin Hu, Wending Huang, Zhengwang Sun, Hui Ye, Kwong Man, Qifeng Wang, Yangbai Sun, Wangjun Yan

Open access · greenAbstract read
In one paragraph

Article in The EPMA journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 2 pooled it
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 2 syntheses or guidelines pooled it, 9 citations in OpenAlex.

  1. A critical appraisal of clinical practice guidelines on surgical treatments for spinal metastasis.European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society · 2024
    Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 3 countries.

Xianglin Hu *Department of Musculoskeletal Surgery, Fudan University Shanghai Cancer Center, Shanghai, 200032 China.
Wending Huang *Department of Musculoskeletal Surgery, Fudan University Shanghai Cancer Center, Shanghai, 200032 China.
Zhengwang Sun *Department of Musculoskeletal Surgery, Fudan University Shanghai Cancer Center, Shanghai, 200032 China.
Hui YeSimmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX 75390 USA.
Kwong ManDepartment of General Surgery, University Hospital of Macau University of Science and Technology, Macau, 999078 China.
Qifeng WangDepartment of Pathology, Fudan University Shanghai Cancer Center, Shanghai, 200032 China.
Yangbai SunDepartment of Musculoskeletal Surgery, Fudan University Shanghai Cancer Center, Shanghai, 200032 China.
Wangjun YanDepartment of Musculoskeletal Surgery, Fudan University Shanghai Cancer Center, Shanghai, 200032 China.ORCID 0000-0001-9178-0687
Shanghai Medical College of Fudan University · CNFudan University Shanghai Cancer Center · CNMacau University of Science and Technology · MOThe University of Texas Southwestern Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Bone metastasis (BM) and skeletal-related events (SREs) happen to advanced lung cancer (LC) patients without warning. LC-BM patients are often passive to BM diagnosis and surgical treatment. It is necessary to guide the diagnosis and treatment paradigm for LC-BM patients from reactive medicine toward predictive, preventive, and personalized medicine (PPPM) step by step. Methods: Two independent study cohorts including LC-BM patients were analyzed, including the Surveillance, Epidemiology, and End Results (SEER) cohort ( Results: The BM incidence rate in LC patients grew (from 17.53% in 2010 to 19.05% in 2016). Liver metastasis was a significant risk factor for BM (OR = 4.53, 95% CI = 4.38-4.69) and poor prognosis (HR = 1.29, 95% CI = 1.25-1.32). The individualized nomogram exhibited good predictive performance for BM risk stratification (AUC = 0.784, 95%CI = 0.781-0.786). Younger patients, males, patients with high invasive LC, and patients with other distant site metastases should be prioritized for BM prevention. Spine is the most common site of BM, causing back pain (91.5%), pathological vertebral fracture (27.1%), and difficult walking (25.4%). Spinal surgery with personalized spinal reconstruction significantly relieved pain and improved daily activities. Perioperative inflammation, immune, and nutrition abnormities warrant personalized managements. Radiotherapy needs to be recommended for specific postoperative individuals. Conclusions: The presence of liver metastasis is a strong predictor of LC-BM. It is recommended to take proactive measures to prevent BM and its SREs, particularly in young patients, males, high invasive LC, and LC with liver metastasis. BM surgery and perioperative management are personalized and required. In addition, adjuvant radiation following separation surgery must also be included in PPPM-guided management. Graphical abstract: Supplementary Information: The online version contains supplementary material available at 10.1007/s13167-022-00270-9.

Indexed as

Adjuvant radiationBone metastasisCancerLung cancerMetastatic spinal tumorsMultidisciplinary teamPerioperative managementPersonalization of medical servicesPredictive factorsPredictive preventive personalized medicine (PPPM)Risk assessmentSurgeryTargeted prevention

Identifiers

PMID35273659
PMCPMC8897531
OpenAlexW4206737593

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.